By Patrice Kelly, Senior Policy Executive Advisor, NDASA (on detail from the U.S. Department of Transportation) When you read a regulatory provision that does not make sense to you, you should pause and ask yourself if you are reading it correctly. You also should...
Resources
Featured posts
All posts
Operating a successful second chance policy and program
By Working Partners® When talking to employers about their current challenges, chances are good that you hear about their difficulty finding and retaining good employees. Part of the challenge is attributed to the unemployment rate, while other factors include a lean,...
Introducing the International Association of Medical Review Officers
By Nadine Wentzell, Chair, IAMRO As Chair of the above-noted body, I am pleased to introduce our recently formed not-for-profit specialty organization. I suspect this is a new entity to most readers of this newsletter, and as such, my intent here is to provide you...
Navigating workplace challenges: DOT substance abuse compliance made simple
By Sandra Serrano, Chief Development Officer, America Substance Abuse Professionals, Inc. (ASAP) Substance use in the workplace presents significant challenges for employers, especially when a well-developed program isn’t already in place. Imagine discovering during a...
Staying Current: Updating a drug screening policy for oral fluid testing
By Bill Current, founder of the Current Consulting Group For many years, oral fluid testing was considered an “emerging technology” as lab-based urine testing dominated the drug testing industry. But that appears to be changing thanks in large part to the Department...
The Case for comprehensive Medical Review Officer (MRO) oversight: Your shield against legal risks and ensuring integrity
By National MRO Within the drug testing industry, Medical Review Officers (MROs) play a critical role in interpreting laboratory results and ensure drug testing programs are scientifically valid and legally defensible. For regulated testing, the U.S. Department of...
The value of using Employment and Insurance (E&I) rapid testing device classification
By Bill Current of the Current Consulting Group & Brian Drake of Wondfo USA Rapid-result drug testing is growing in popularity among employers. In Current Consulting Group’s (CCG) 2024 Employer Drug Testing Survey, co-sponsored by Wondfo USA, 45% of respondents...
No duty? You win! The legal concept of duty in workplace drug testing
By William J. Judge, JD, LL.M., and Nick Hartman, Drug Screening Compliance Institute Background It has been estimated that as many as 45 million workplace drug tests are conducted each year in the United States. The most recent Quest Diagnostics Drug Testing Index...
Fentanyl and fentanyl analogs: Prevalence and challenges
By Sabra Jones and Chris Heartsill, Regional Toxicology Liaisons, National Highway Traffic Safety Administration, Regions 5 and 7 Per the Centers for Disease Control, overdose deaths remain the leading cause of injury-related deaths in the United States1 and fentanyl...
“They never trained me for this!” What to do if what happens during the collection is not in the regulations
By Patrice Kelly, Senior Policy Executive Adviser, NDASA, (on detail from the US Department of Transportation) The United States Department of Transportation (DOT) regulation, 49 CFR Part 40 (Part 40), and most collector training courses are written to address what...